Morepen Laboratories
Gurugram, Haryana, India
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (2)
○ Clinical Trials
○ SEC Filings
✓ Press (8)
○ EMA GMP
○ MHRA GMP
Quick Facts: Morepen Laboratories
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Gurugram, Haryana, India
- Website
- https://www.morepen.com/cdmo
- Modalities
- Small Molecule API, Custom Synthesis
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Morepen Laboratories
Morepen Laboratories makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API, Custom Synthesis. 1 manufacturing site registered with the U.S. FDA. Website: https://www.morepen.com/cdmo
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Morepen Laboratories FDA Inspection History
2026-04
2023-03
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2026-04-17 |
Morepen Laboratories Limited
Solan
Company-level
|
Drug Quality Assurance | No | No Action Indicated (NAI) |
| 2023-03-24 |
Morepen Laboratories Limited
Baddi, Solan
Company-level
|
Drug Quality Assurance | No | No Action Indicated (NAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Company Signals 8 articles
Company announcements, not verified evidence. They do not change any score.
Morepen Laboratories Q2 Revenue Rises 81% To Rs 755 Crore As CDMO Business Scales Up - BW Healthcare World
Morepen Laboratories Q2 Revenue Rises 81% To Rs 755 Crore As CDMO Business Scales Up BW Healthcare World
Morepen Laboratories posts record Rs 755-cr Q2 revenue; EBITDA soars 273% to Rs 132 cr - Indian Pharma Post
Morepen Laboratories posts record Rs 755-cr Q2 revenue; EBITDA soars 273% to Rs 132 cr Indian Pharma Post
Morepen Laboratories Q2 Results: Revenue Rises 81% YoY - HDFC Sky
Morepen Laboratories Q2 Results: Revenue Rises 81% YoY HDFC Sky
Morepen Laboratories reports record Q2 2026 revenue of Rs. 755 Cr with EBITDA soaring by 273% - Business Upturn
Morepen Laboratories reports record Q2 2026 revenue of Rs. 755 Cr with EBITDA soaring by 273% Business Upturn
Morepen Laboratories (NSE:MOREPENLAB) Reaches 614 KL API and CDMO Capacity, Files First US ANDA - Kalkine India
Morepen Laboratories (NSE:MOREPENLAB) Reaches 614 KL API and CDMO Capacity, Files First US ANDA Kalkine India
Morepen Laboratories Delivers Record Q2, H1 FY27 Performance, With CDMO And Exports Driving Strong Growth - Free Press Journal
Morepen Laboratories Delivers Record Q2, H1 FY27 Performance, With CDMO And Exports Driving Strong Growth Free Press Journal
Morepen Laboratories: Even After a 150% Gain, How Does Q2 Hold the Key to Another Rally? - Trade Brains
Morepen Laboratories: Even After a 150% Gain, How Does Q2 Hold the Key to Another Rally? Trade Brains
Morepen Laboratories Files First US ANDA for Sitagliptin - Machine Maker
Morepen Laboratories Files First US ANDA for Sitagliptin Machine Maker
Frequently Asked Questions About Morepen Laboratories
How many FDA inspections does Morepen Laboratories have on record?
CDMO Signal tracks 2 FDA inspections for Morepen Laboratories, sourced from the FDA inspection database. See the full inspection history above.
Has Morepen Laboratories received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Morepen Laboratories.
Does Morepen Laboratories have a CDMO Signal Score?
Not yet. Morepen Laboratories is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Morepen Laboratories for a manufacturing program?
Use the free AI matchmaker to compare Morepen Laboratories against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Divi's Laboratories
Hyderabad, Telangana, India
Small Molecule API, Intermediates, Custom Synthesis, Peptides
Apicore
India
Small Molecule API, Custom Synthesis
Unimark Remedies
India
Small Molecule API, Custom Synthesis
Alivus Life Sciences
Ahmedabad, India
Small Molecule API, Intermediates, Custom Synthesis
Indoco Remedies
Mumbai, India
Small Molecule API, Intermediates, Custom Synthesis, Oral Solid Dose, Topicals
Compare Morepen Laboratories with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.